Latest Trending
Last Updated, Nov 2, 2023, 3:48 PM
Obesity Drug Demand Outstrips Supply

[ad_1]

Eli Lilly’s blockbuster diabetes medication Mounjaro is expected to receive Food and Drug Administration approval as an obesity treatment before the end of the year, which would lead to a surge in demand. Whether there will be enough of the drug is a different question. 

Both Lilly and its competitor, Denmark’s Novo Nordisk, which makes Ozempic and its sister drug Wegovy, are struggling to meet skyrocketing demand for their medications. There is no quick fix for that given the complexity of building out manufacturing capacity for the injections. Both companies are investing billions of dollars a year to try to catch up.

Copyright ©2023 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8

[ad_2]

Source link

24World Media does not take any responsibility of the information you see on this page. The content this page contains is from independent third-party content provider. If you have any concerns regarding the content, please free to write us here: contact@24worldmedia.com

Latest Post

Large part of Lynn Woods remains closed

Last Updated,Nov 30, 2024

Swampscott water tests lead-free – Itemlive

Last Updated,Nov 29, 2024

Mother needs help providing the Christmas experience

Last Updated,Nov 29, 2024

A cheerful fundraiser for Saugus team

Last Updated,Nov 29, 2024

Carl Daniel Reiter – The Suffolk Times

Last Updated,Nov 29, 2024

Joan Ann (Woessner) Polywoda – The Suffolk Times

Last Updated,Nov 29, 2024

Thomas L. Lewick – The Suffolk Times

Last Updated,Nov 29, 2024

Jeanette Howard – The Suffolk Times

Last Updated,Nov 29, 2024

Nina Mazzaferro – The Suffolk Times

Last Updated,Nov 29, 2024

Lynn mayor announces re-election bid

Last Updated,Nov 29, 2024

BARRETT: They ate plenty – Itemlive

Last Updated,Nov 29, 2024

Brooke Moloney, the Minutewoman – Itemlive

Last Updated,Nov 29, 2024